Search results :

Rosuvastatin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: C10AA07

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11
Headache common, 3.1% - 8.5% 5% - 5.3% x x x x x x x x x x x
Dizziness common, 4% 2.8% x x x x x x x x x x x
Arthralgia very rare — 3.8% - 10.1% 3.2% - 7.1% x x x x x x x x x x x
Nausea common, 0% - 6.3% 2.3% - 3.1% x x x x x x x x x x x
Myalgia postmarketing — 1.9% - 12.7% 1.3% - 12.1% x x x x x x x x x x x
Constipation common, 2.1% - 4.7% 2.4% - 3% x x x x x x x x x x x
Diabetes mellitus 2.8% 2.3% x x x x x x
Asthenia common, 0.9% - 4.7% 2.6% x x x x x x x x x x x
Abdominal pain common, 2.4% 1.8% x x x x x x x x x x x
Rash uncommon x x x x x x x x x x x
Pruritus uncommon x x x x x x x x x x x
Urticaria uncommon x x x x x x x x x x x
Amnesia postmarketing x x x x x
Angioedema rare x x x x x x x x x x x
Arrhythmia postmarketing x x
Mental disorder postmarketing x x
Breast disorder postmarketing x x
Confusional state postmarketing x x x x x x x
Depression postmarketing x
Gynaecomastia very rare, postmarketing x x x x x x x
Blood disorder postmarketing x x
Hepatitis very rare, postmarketing x x x x x x x x x x x
Hypersensitivity rare x x x x x x x x x x x
Jaundice very rare, postmarketing x x x x x x x x x x x
Renal failure acute postmarketing x x x x x x x x x x
Myopathy rare x x x x x x x x x x x
Musculoskeletal disorder postmarketing x x
Myoglobinuria postmarketing x x x x x x x x x x
Myositis rare x x x x x x x x x x x
Nightmare postmarketing x x x x x x x x
Pancreatitis rare x x x x x x x x x x x
Neuropathy peripheral postmarketing x
Rhabdomyolysis very rare — rare x x x x x x x x x
Thrombocytopenia postmarketing x x x x
Hepatic failure postmarketing x x x x x x x x x x
Muscular weakness postmarketing x x
Memory impairment postmarketing x x x x x
Hepatobiliary disease postmarketing x x x
Muscle swelling postmarketing x x
Cognitive impairment postmarketing x x x x x
Forgetfulness postmarketing x x x x x
Drug interaction postmarketing x x
Memory loss very rare, postmarketing x x x x x x x x x x x
Sleep disorder postmarketing x x x x x x x x
Insomnia postmarketing x x x x x x x x x
Immune-mediated necrotising myopathy postmarketing x x x x x x
Nervous system disorder very rare, postmarketing x x x
Bronchitis x
Infection x
Diarrhoea x
Dyspepsia x
Flatulence x
Gastroenteritis x
Haematuria x x
Influenza x
Nephropathy x
Hypertonia x
Pain x x x
Paraesthesia x
Pharyngitis x
Proteinuria x x x x x x x x x x
Rhinitis x
Sinusitis x
Urinary tract infection x
Creatine phosphokinase increased x x x x x x
Accidental injury x
Hepatic enzyme increased x x x x x x x x x x
Microscopic hematuria x x x x x x x x x
Urine analysis abnormal x
Cough increased x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ROSUVASTATIN (ROSUVASTATIN CALCIUM) / CRESTOR - 40MG

Side effects:43
Source:Health Canada

ROSUVASTATIN CALCIUM

Side effects:26
Source:FDA Structured Product Label

ROSUVASTATIN CALCIUM

Side effects:26
Source:FDA Structured Product Label

ROSUVASTATIN CALCIUM

Side effects:31
Source:FDA Structured Product Label

ROSUVASTATIN

Side effects:36
Source:FDA Structured Product Label

ROSUVASTATIN

Side effects:38
Source:FDA Structured Product Label

ROSUVASTATIN

Side effects:38
Source:FDA Structured Product Label

ROSUVASTATIN

Side effects:39
Source:FDA Structured Product Label

ROSUVASTATIN

Side effects:40
Source:FDA Structured Product Label

Rosuvastatin Calcium Film-Coated Tablets / CAVSTAT

Side effects:42
Source:medicines.org.au

Rosuvastatin calcium / ROSUVASTATIN & 40 MG TABLETS

Side effects:45
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label